FDA Talks Drug Safety With China, But Visas For Staff Still Elusive
Executive Summary
Agency unable to place more inspectors in China even as Howard Sklamberg visits Beijing.
You may also be interested in...
US FDA's China Staff Increase Takes Hold As Gottlieb Boosts Border Security
After receiving delayed visas, additional FDA is inspectors and other staff can relocate to China office; Gottlieb also announces increase in international mail facility staff.
How FDA Plans To Stop Worrying And Love Globalization
New deputy commissioner Howard Sklamberg tells “The Pink Sheet” that globalization of the drug supply eventually will become more commonplace, and ideally less of a concern, for American consumers.
FDA Inspection Growth In China Stymied By Visa Issues
The agency is waiting for approval to locate 10 new drug inspectors in China.